Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990: a systematic analysis and implications. Lancet. 2012;379:2162–72.
Inoue H, Ochiai M, Yasuoka K, Tanaka K, Kurata H, Fujiyoshi J, Neonatal Research Network of Japan (NRNJ), et al. Early mortality and morbidity in infants with birth weight of 500 grams or less in Japan. J Pediatr. 2017;190:112–7
Gilbert C. Changing challenges in the control of blindness in children. Eye Lond. 2007;21:1338–43.
Article CAS PubMed Google Scholar
Darlow BA, Lui K, Kusuda S, Reichman B, Håkansson S, Bassler D, et al. International variations and trends in the treatment for retinopathy of prematurity. Br J Ophthalmol. 2017;101:1399–404.
Hiraoka M, Watanabe T, Kawakami T, Ito R, Takigawa I, Suzumura H, et al. Retinopathy of prematurity in extremely low birth weight infants: a Tokyo multicenter study. Nippon Ganka Gakkai Zasshi. 2004;108:600–5 (in Japanese).
Tachikawa T, Takei M, Kiyota M, Saito Y, Azuma N, Nishina S, et al. Retinopathy of prematurity in extremely low-birth-weight infants: a multicenter study in Tokyo. Nippon Ganka Gakkai Zasshi. 2017;122:103–13 (in Japanese).
Tachikawa T, Kiyota M, Yoshida T, Nishina S, Noda E, Konno E, et al. Retinopathy of prematurity in extremely low-birth-weight infants: a Tokyo multicenter study (3rd report). Nippon Ganka Gakkai Zasshi. 2024;128:401–9 (in Japanese).
Ministry of Health, Labour and Welfare, Japan. Vital statistics of Japan. https://www.e-stat.go.jp/dbview?sid=0003411637 Accessed 21 Dec 2024. (in Japanese)
International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991–9.
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Chan RV, Berrocal A, et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. 2021;128:e51–68
Sasaki Y, Ikeda T, Nishimura K, Katsuragi S, Sengoku K, Kusuda S, et al. Association of antenatal corticosteroids and mode of delivery with mortality and morbidity of infants weighing <1,500 g at birth in Japan. Neonatology. 2014;106:81–6.
Article CAS PubMed Google Scholar
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454.
Tyson JE, Parikh NA, Langer J, Green C, Higgins RD, NICHD Neonatal Research Network. Intensive care for extreme prematurity—moving beyond gestational age. N Engl J Med. 2008;358:1672–81.
Article CAS PubMed PubMed Central Google Scholar
Movsas TZ, Spitzer AR, Gewolb IH. Postnatal corticosteroids and risk of retinopathy of prematurity. J AAPOS. 2016;20:348–52.
Ehret DE, Edwards EM, Greenberg LT, Bernstein IM, Buzas JS, Soll RF, et al. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 weeks’ gestation. JAMA Netw Open. 2018;1:e183235.
Article PubMed PubMed Central Google Scholar
Kim JK, Hwang JH, Lee MH, Chang YS, Park WS. Mortality rate-dependent variations in antenatal corticosteroid-associated outcomes in very low birth weight infants with 23–34 weeks of gestation: a nationwide cohort study. PLoS ONE. 2020;15:e0240168.
Article CAS PubMed PubMed Central Google Scholar
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618–37.
Article PubMed PubMed Central Google Scholar
Hylander MA, Strobino DM, Pezzullo JC, Dhanireddy R. Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants. J Perinatol. 2001;21:356–62.
Article CAS PubMed Google Scholar
Bharwani SK, Green BF, Pezzullo JC, Bharwani SS, Dhanireddy R. Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update. J Perinatol. 2016;36:913–20.
Article CAS PubMed Google Scholar
Arslanoglu S, Corpeleijn W, Moro G, Braegger C, Campoy C, Colomb V, et al. Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr. 2013;57:535–42.
Committee on Nutrition, American Academy of Pediatrics. Donor human milk for the high-risk infant: preparation, safety, and usage options in the United States. Pediatrics. 2017;139:e20163440.
Stutchfield CJ, Jain A, Odd D, Williams C, Markham R. Fetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study. Eye Lond. 2017;31:1451–5.
Article CAS PubMed PubMed Central Google Scholar
Jiramongkolchai K, Repka MX, Tian J, Aucott SW, Shepard J, Collins M, PacIFiHER Study Group, et al. Lower fetal haemoglobin levels at 31 and 34 weeks’ postmenstrual age are associated with the development of retinopathy of prematurity. Eye (Lond). 2021;35:659–64
Hellström W, Martinsson T, Morsing E, Gränse L, Ley D, Hellström A. Low fraction of fetal haemoglobin is associated with retinopathy of prematurity in the very preterm infant. Br J Ophthalmol. 2022;106:970–4.
Teofili L, Papacci P, Dani C, Cresi F, Remaschi G, Pellegrino C, et al. Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial. Ital J Pediatr. 2024;50:142.
Article CAS PubMed PubMed Central Google Scholar
Roberts JD, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group. N Engl J Med. 1997;336:605–10
Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819–20.
Article CAS PubMed Google Scholar
Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomized controlled trial. Lancet. 2019;394:1551–9.
Article CAS PubMed PubMed Central Google Scholar
Stahl A, Sukgen EA, Wu WC, Lepore D, Nakanishi H, Mazela J, et al. Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial. JAMA. 2022;328:348–59.
Article CAS PubMed PubMed Central Google Scholar
Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity. Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–96.
Comments (0)